Risk communication in non-EU countries

What is it about?

Communicating safety information to patients and healthcare professionals is a public health responsibility and is essential for achieving the objectives of pharmacovigilance in terms of promoting the rational, safe and effective use of medicines, preventing harm from adverse reactions, minimising risks and contributing to the protection of patients and public health. The main emphasis of this article is on direct healthcare professional communication (DHPC). Countries of interest are Macedonia, Serbia, Bosnia & Herzegovina, Montenegro, Albania and Kosovo.

Featured Image

Why is it important?

Readers will get an indepth look at regulation compliance from the emerging markets within country-specific environments.

Perspectives